Sh2022 Abernethy Amy

Amy Abernethy

President, Clinical Research Platforms, Verily

Amy Abernethy is president of clinical research platforms at Alphabet’s Verily, where she has responsibility for the company’s Baseline program and other initiatives to support clinical trials and real-world evidence studies. Before joining Verily, Abernethy was principal deputy commissioner and acting chief information officer of the US Food and Drug Administration. Prior roles include serving as chief medical officer and chief scientific officer of Flatiron Health and multiple roles at Duke University, where she was professor of medicine.

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
aerial 2019 campus
Sign up to receive the latest news from Aspen Ideas.